Precigen (PGEN) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PGEN Precigen

Watchlist

1.960
-0.020-1.01%

Close Feb 14 16:00 ET

1.980
+0.020+1.02%

Post 19:18 ET

574.02MMarket Cap-3.63P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Precigen Shares Are Trading Higher After HC Wainwright & Co. Raised Its Price Target on the Stock From $4 to $6.
BenzingaJan 23 10:29 ET
Knight-Swift Transportation Posts Upbeat Earnings, Joins TAL Education, LSI Industries, GE Aerospace And Other Big Stocks Moving Higher On Thursday
BenzingaJan 23 09:57 ET
H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $6
Moomoo NewsJan 23 06:34 ET · Ratings
Should You Invest in Precigen (PGEN)?
Yahoo FinanceJan 16 09:35 ET
Precigen Analyst Ratings
BenzingaJan 14 09:33 ET · Ratings
Precigen's Strategic Advancements and Pipeline Developments Drive Buy Rating
TipRanksJan 13 18:25 ET · Ratings

Comments

stderr

Feb 5 13:41

$Precigen (PGEN.US)$ What's going on, will it hold or deflate?

HenryRen

Dec 31 13:01

$Precigen (PGEN.US)$
go go go

Share Your Profit/Loss

Jaguar8

Dec 30, 2024 18:59

NEWS TODAY

$Precigen (PGEN.US)$
Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Monday, 30th December at 7:00 am
– PRGN-2012 has the potential to be the first FDA-approved therapeutic for the treatment of adults with RRP, a rare and devastating chronic disease for which the current standard-of-care is repeated surgeries –
– PRGN-2012 received Breakthrough Therapy Designation fr...

Moomoo AI

Jan 26, 2024 06:18

The company's share price decline mirrors its poor fundamental performance. The recent loss isn't as severe as the 13% annual loss investors endured over the past five years. Key metrics need improvement to generate enthusiasm.

Strong Week for Precigen (NASDAQ:PGEN) Shareholders Doesn't Alleviate Pain of Three-year Loss

Trytosaveabit

Jan 16, 2024 07:10

News

$Precigen (PGEN.US)$Moomoo 24/7· 3 mins ago
Precigen Receives Orphan Drug Designation For PRGN-2012 For Treatment Of Recurrent Respiratory Papillomatosis From The European Commission

PGEN Precigen

Trade Overview

Capital Trend

News

Comments

Trending Stocks